/ /

Charles J. Lockwood, MD, MHCM
Dr. Lockwood, Editor-in-Chief, is Dean of the Morsani College of Medicine and Senior Vice President of USF Health, University of South Florida, Tampa. He can be reached at [email protected]
Restricting Duty Hours Where is the Evidence
A discussion regarding resident duty hours as we approach the 10th anniversary of resident duty hour restrictions.
Medical costs--Incomprehensible and unsustainable
You may or may not have read Bitter Pill: Why Medical Bills are Killing Us, the cover story of the March 4, 2013, issue of Time magazine. However, I am confident your hospital administrators have read the article and were furious.
Should pregnant women receive iodine supplementation?
Should pregnant women receive iodine supplementation?
US obstetricians need to once again be concerned about maternal iodine deficiency.
Restricting resident duty hours- Where is the evidence
Resident duty hour restrictions became the way of life after the Libby Zion case in 1984, but have these restrictions actually done anything for patient safety?
A crystal-ball view of healthcare in 2016
Contemporary OB/GYN's Editor-in-Chief makes his predictions about where healthcare is headed over the next four years.
Healthcare's Age of Uncertainty
Physicians should be no strangers to change, but recent events have led to an period of uncharacteristic uncertainty.
Obamacare and the ob/gyn: More questions than answers
Are you wondering what the recent ACA Supreme Court decision means for OB/GYNs? Contemporary OB/GYN's editor-in-chief tries to figure it out.
In this protocol, Dr. Lockwood reviews the pathophysiology, diagnosis, and treatment of autoimmune disease in pregnancy. Included are guidelines for management of systemic lupus erythematous (SLE), rheumatoid arthritis (RA), scleroderma, and rarer autoimmune disorders.
Maternal hypothyroidism: To screen or not to screen?
The debate over universal screening for maternal hypothyroidism has raged for years. Recent concrete data points to just testing at-risk mothers.
Peeling the onion on the link between BRCA1, BRCA2, and ovarian cancer risk and prognosis
While the field of cancer genetics may seem pretty rececnt, ancient Greek physicians observed that the occurrence of breast cancer was more common in certain families. In the late 1800s, Paul Broca, the famous French surgeon and anthropologist best known for discovering the speech production center in the frontal lobe, was one of the first to formally recognize genetic pedigrees in breast cancers.